Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial
Martedì 12 ottobre 2021
circa 1 minuti di lettura
Journal and Affiliations:
Circulation, 12 ottobre 2021
Marco Valgimigli, Cardiocentro Ticino, EOC, Lugano
Tags:
antiplatelet therapy
dual antiplatelet therapy
percutaneous coronary intervention
Authors:
Marco Valgimigli